Director · Caris Life Sciences, Inc. · Common Stock
Side
A
Value
—
Shares
13.2K
Price
—
Executed
Aug 14, 2026
Disclosed
Aug 14, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Aug 14 executedAug 14, 2026 disclosed
CAI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 81.8% of prior position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Gilliam Joseph E filed this Form 4 reporting a grant or award of CAI on Aug 14, 2026. It became public on Aug 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Gilliam Joseph Ecik:0001705850
Issuer
Caris Life Sciences, Inc.cik:0002019410
Revision history · 0
No field has changed since this record was first ingested.
